Home | Welcome to Contract Pharma   
Last Updated Monday, May 20 2013
Print RSS Feed

Breaking News

Related Searches: Financial Reports •
Catalent 1Q

November 13, 2007
Catalent Pharma Solutions 1Q Revenues: $438 million (+10%) 1Q Loss: $11.3 million ($1.1 million in 1Q06 earnings) Comments: Oral Technologies net revenue grew 9% to $235 million, while Sterile Technologies was up 26% to $71 million, fueled b…  Read More »
Pfizer, Nektar Reach Exubera Settlement

November 13, 2007
Pfizer and Nektar Therapeutics have reached an agreement settling their contractual issues regarding Exubera and Nektar's new inhaled insulin product, which is currently in Phase I. Nektar will receive a one-time payment of $135 million from Pfizer t…  Read More »
Alpha Biologics To Manufacture for Synairgen

November 12, 2007
Synairgen, a company developing novel therapies for asthma and COPD, has selected Alpha Biologics to help with the advancement of its growth factor drug development program. Alpha will develop a scaleable manufacturing process for Synairgen's optimiz…  Read More »
Cephalon Submits Fentora sNDA

November 12, 2007
Cephalon has submitted an sNDA to the FDA to market Fentora for the management of breakthrough pain in opioid tolerant patients with chronic pain conditions. Breakthrough pain is characterized by its rapid onset, moderate-to-severe intensity, and rel…  Read More »
Advion Enhances Services

November 12, 2007
Advion BioServices, the bioanalytical services division of Advion BioSciences, Inc., will expand its capacity with the recent acquisition of two Applied Biosystems/MDS Sciex API 5000 mass spectrometers and Waters Acquity UPLC capability. In addition,…  Read More »
PharmEng Opens Mfg. Facility

November 9, 2007
PharmEng International has opened its $15 million pharmaceutical manufacturing facility in Cape Breton, Nova Scotia, Canada. The 46,400-sq.ft. facility, which operates under the name of Keata Pharma, includes offices for PharmEng's pharmaceutical con…  Read More »
Merck Strikes Vioxx Settlement

November 9, 2007
Merck has agreed to make a $4.85 billion settlement fund to end a vast number of Vioxx lawsuits from U.S. patients. The company stressed that this does not constitute a class-action settlement, but that the fund will cover qualified claims on a case-…  Read More »
Catalent Finishes First Batch of Flu Vax

November 9, 2007
Catalent Pharma Solutions, has completed the first influenza vaccine manufacturing campaign at its new prefilled syringe manufacturing facility in Neder-Over-Heembeek, Belgium. The production campaign exceeded 21 million prefilled syringes for the…  Read More »
Shire Licenses 3 Drugs from Amicus

November 8, 2007
Shire plc has licensed three drugs in development from Amicus Therapeutics. The non-U.S. rights cover Amigal for Fabry disease (Phase II), Plicera for Gaucher disease (Phase II) and AT2220 for Pompe disease (Phase I). Shire's chief executive offic…  Read More »
Merck Serono, BioMarin Submit MAA

November 8, 2007
Merck Serono, a division of Merck KGaA, has submitted an MAA to the EMEA for sapropterin dihydrochloride (Kuvan in the U.S.) as an oral treatment for patients suffering from significant hyperphenylalaninemia (HPA) due to phenylketonuria (PKU) or tetr…  Read More »
Hospira 3Q

November 8, 2007
Hospira 3Q Revenues: $838 million (+30%) 3Q Earnings: $59 million (+6%) YTD Revenues: $2.5 billion (+26%) YTD Earnings: $61 million (-68%) Comments: Integration of Mayne Pharma helped drive revenue growth, while restructuring costs dro…  Read More »
Wacker Expands Bio-Facilities in Jena

November 7, 2007
Wacker has announced plans to invest $30 million to expand its facility in Jena, Germany. The expansion will cover the GMP production facility as well as the construction of a new building for process development and quality control. "The ne…  Read More »
Cephalon, PsychoGenics Enter Neuro Pact

November 7, 2007
PsychoGenics and Cephalon have entered into a drug discovery agreement. Cephalon will supply compounds that are prospectively suitable for neuropsychiatric disorders to PsychoGenics for evaluation using its proprietary drug discovery technologies.…  Read More »
AAIPharma Adds Budapest Team

November 7, 2007
AAIPharma has expanded its operations in Central and Eastern Europe with the addition of a team in Hungary. The new office is in Budapest and will initially consist of seven staff. The group in Hungary has therapeutic expertise in the areas of onc…  Read More »
Bayer AG Suspends Trasylol Sales

November 6, 2007
Bayer AG has suspended sales of Trasylol, an anti-bleeding drug, at the request of  the FDA and foreign health officials pending further analysis of a Canadian study that suggests it's linked to a 50% higher risk of death than the other drugs in…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: